Abiopharma

🔍 Giem Judi (Executive)

Company: COLUMBIA BANKING SYSTEM, INC. (COLB)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 2,393 shares of Common Stock at $32.69 per share (Direct)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,393.00 | transaction_form_type: 4
• Sold 643 shares of Common Stock at $32.69 per share (Direct)
  Date: 2026-08-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,750.00 | transaction_form_type: 4
• Sold 2,393 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 13,108.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1

Footnotes:

• F1: Restricted Stock Units convert into common stock on a one-for-one basis. On July 22, 2025, the reporting person was granted 7,179 Restricted Stock Units, which vest in three annual installments beginning on August 14, 2026.